[go: up one dir, main page]

BRPI0510084A - benzoxazina para tratamento de doenças do trato respiratório - Google Patents

benzoxazina para tratamento de doenças do trato respiratório

Info

Publication number
BRPI0510084A
BRPI0510084A BRPI0510084-4A BRPI0510084A BRPI0510084A BR PI0510084 A BRPI0510084 A BR PI0510084A BR PI0510084 A BRPI0510084 A BR PI0510084A BR PI0510084 A BRPI0510084 A BR PI0510084A
Authority
BR
Brazil
Prior art keywords
respiratory tract
benzoxazine
treatment
tract diseases
relates
Prior art date
Application number
BRPI0510084-4A
Other languages
English (en)
Inventor
Thierry Bouyssou
Ingo Konetzki
Sabine Pestel
Andreas Schnapp
Christoph Hoenke
Philipp Lustenberger
Klaus Rudolf
Kurt Schromm
Frank Buettner
Claudia Heine
Hermann Schollenberger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BRPI0510084A publication Critical patent/BRPI0510084A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

BENZOXAZINA PARA TRATAMENTO DE DOENçAS DO TRATO RESPIRATóRIO. A presente invenção refere-se ao uso dos compostos de fórmula geral <UM>1<MV>, em que os grupos R¬ 1¬, R¬ 2¬ e R¬ 3¬ podem ter os significados dados nas reivindicações e na descrição. A invenção também refere-se á produção de um medicamento para o tratamento de doenças do trato respiratório.
BRPI0510084-4A 2004-04-22 2005-04-18 benzoxazina para tratamento de doenças do trato respiratório BRPI0510084A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
PCT/EP2005/004075 WO2005102350A1 (de) 2004-04-22 2005-04-18 Benzoxazine zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number Publication Date
BRPI0510084A true BRPI0510084A (pt) 2007-10-16

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510084-4A BRPI0510084A (pt) 2004-04-22 2005-04-18 benzoxazina para tratamento de doenças do trato respiratório

Country Status (20)

Country Link
EP (1) EP1765355B1 (pt)
JP (1) JP2007533684A (pt)
KR (2) KR20130042662A (pt)
CN (1) CN1946406A (pt)
AU (1) AU2005235420C1 (pt)
BR (1) BRPI0510084A (pt)
CA (1) CA2559700C (pt)
DE (1) DE102004019539A1 (pt)
DK (1) DK1765355T3 (pt)
EA (1) EA012045B1 (pt)
EC (1) ECSP066948A (pt)
ES (1) ES2403184T3 (pt)
IL (1) IL177663A (pt)
NO (1) NO20065061L (pt)
NZ (1) NZ551272A (pt)
PL (1) PL1765355T3 (pt)
SG (1) SG152233A1 (pt)
UA (1) UA85707C2 (pt)
WO (1) WO2005102350A1 (pt)
ZA (1) ZA200606547B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
PL1917253T3 (pl) 2005-08-15 2015-06-30 Boehringer Ingelheim Int Sposób wytwarzania betamimetyków
JP2009514933A (ja) * 2005-11-09 2009-04-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入用エアロゾル製剤
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP2231642B1 (en) 2008-01-11 2013-10-23 Novartis AG Pyrimidines as kinase inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
PH12013501758A1 (en) 2011-02-25 2013-10-14 Irm Llc Pyrazolo [1,5-a] pyridines as trk inhibitors
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
EP3551187B1 (en) 2016-12-12 2021-02-17 Boehringer Ingelheim International GmbH Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
EA200201056A1 (ru) * 2000-04-27 2003-04-24 Бёрингер Ингельхайм Фарма Кг Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
DE102004019539A1 (de) 2005-11-10
JP2007533684A (ja) 2007-11-22
UA85707C2 (ru) 2009-02-25
KR20130042662A (ko) 2013-04-26
WO2005102350A1 (de) 2005-11-03
EA012045B1 (ru) 2009-08-28
CA2559700A1 (en) 2005-11-03
CN1946406A (zh) 2007-04-11
KR101338947B1 (ko) 2013-12-10
ZA200606547B (en) 2008-04-30
AU2005235420A1 (en) 2005-11-03
NO20065061L (no) 2006-11-07
SG152233A1 (en) 2009-05-29
EA200601837A1 (ru) 2007-04-27
AU2005235420C1 (en) 2011-02-24
ECSP066948A (es) 2006-12-20
EP1765355B1 (de) 2013-03-06
DK1765355T3 (da) 2013-04-08
ES2403184T3 (es) 2013-05-16
PL1765355T3 (pl) 2013-08-30
IL177663A0 (en) 2006-12-31
AU2005235420B2 (en) 2010-10-28
KR20070054599A (ko) 2007-05-29
NZ551272A (en) 2010-10-29
EP1765355A1 (de) 2007-03-28
CA2559700C (en) 2013-06-11
IL177663A (en) 2014-04-30

Similar Documents

Publication Publication Date Title
BRPI0510084A (pt) benzoxazina para tratamento de doenças do trato respiratório
BRPI0717367B8 (pt) di-hidropirazolonas substituídas, seus usos e seu processo de preparação, e medicamento
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BR112012009214A2 (pt) compostos
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
TR200901979T2 (tr) Antikolinerjik etkili bileşik ve ?-mimetikler bazında yeni ilaç bileşimleri.
BRPI0515592A (pt) medicamentos compreendendo compostos de carbonila, e o uso dos mesmos
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BRPI0610850A2 (pt) derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados
BR0316264A (pt) Medicamento para tratamento de doença pulmonar obstrutiva crÈnica
EA200802213A1 (ru) Способы лечения заболеваний крови
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
ECSP045353A (es) Derivados de benzoxazinona, su preparación y aplicación como medicamentos
BRPI0913291A2 (pt) composto, pró-droga, medicamento, métodos para diminuir a proteína 4 ou tratamento de diabete em um mamífero, e, uso do composto
BRPI0514133A (pt) compostos de fórmula i, processo para a sua fabricação, composições farmacêuticas, método para o tratamento e/ou profilaxia de doença que são mediadas por inibidores de cetp e uso dos compostos de fórmula i
BRPI0510080A (pt) combinações farmacêuticas contendo benzoxazina para tratar doenças respiratórias
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
BRPI0515582A (pt) 3-(2-hidroxifenil)pirazóis e seu uso como moduladores de hsp90
BRPI0513819A (pt) inibidores de hsp90
BRPI0607258A2 (pt) uso, composto, bem como formulações farmacêuticas
BRPI0513744A (pt) derivados de guanidina e usos terapêuticos dos mesmos
BRPI0411209A (pt) uso de derivados isoindolinona como inseticidas
DK1809288T3 (da) Anvendelse af 1,4-bis-(3-aminoalkyl)piperazinderivater ved behandling af neurodegenerative sygdomme
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
BRPI0519351A2 (pt) medicamentos para o tratamento ou prevenÇço de doenÇas fibràticas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.